aTyr Pharma, Inc.

NasdaqCM:ATYR Stock Report

Market Cap: US$313.9m

aTyr Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ATYR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 Jul 24BuyUS$184,613Paul SchimmelIndividual100,000US$1.93
05 Jun 24BuyUS$9,276Nancy E. KruegerIndividual5,000US$1.86
31 May 24BuyUS$36,140Sanjay ShuklaIndividual20,000US$1.81
31 May 24BuyUS$8,950Jill ChurchIndividual5,000US$1.79
30 May 24BuyUS$87,500Timothy CoughlinIndividual50,000US$1.75

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ATYR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,987,4622.37%
Hedge Funds5,039,8466%
General Public29,034,19334.6%
Institutions47,880,90657%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 43.3%.

Top Shareholders

Top 25 shareholders own 63.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.5%
Federated Hermes, Inc.
14,666,600US$54.9m0%0.13%
13.5%
FMR LLC
11,369,429US$42.5m9.83%no data
6%
Point72 Asset Management, L.P.
5,039,846US$18.8m30,500%0.05%
3.56%
The Vanguard Group, Inc.
2,987,578US$11.2m12.7%no data
2.93%
Tikvah Management LLC
2,460,833US$9.2m0%2.55%
2.38%
Logos Global Management, L.P.
2,000,000US$7.5m-33.3%0.92%
2.07%
Checkpoint Capital, LLC, Asset Management Arm
1,736,477US$6.5m-10.8%3.32%
2.06%
Alyeska Investment Group, L.P.
1,728,538US$6.5m-7.45%0.03%
2.01%
Woodline Partners LP
1,683,549US$6.3m0.02%0.05%
1.66%
BlackRock, Inc.
1,396,562US$5.2m0.32%no data
1.37%
Renaissance Technologies LLC
1,149,175US$4.3m-11.2%0.01%
1.31%
Paul Schimmel
1,101,056US$4.1m9.99%no data
1.19%
Adage Capital Management, L.P.
1,000,000US$3.7m0%0.01%
1.15%
Citadel Advisors LLC
966,607US$3.6m-47.6%no data
0.96%
Geode Capital Management, LLC
809,101US$3.0m22.1%no data
0.95%
Ghost Tree Capital, LLC
800,000US$3.0m0%1.17%
0.8%
Tang Capital Management, LLC
671,134US$2.5m0%0.18%
0.7%
Laurence Lytton
585,013US$2.2m0%no data
0.46%
Schonfeld Strategic Advisors LLC
386,584US$1.4m894%0.01%
0.34%
GSA Capital Partners LLP
286,600US$1.1m-11.1%0.08%
0.2%
State Street Global Advisors, Inc.
168,308US$629.5k0%no data
0.17%
Dimensional Fund Advisors LP
145,524US$544.3k0%no data
0.17%
Qube Research & Technologies Ltd
139,155US$520.4k73,900%no data
0.16%
Sanjay Shukla
136,548US$510.7k0%no data
0.16%
Susquehanna International Group, LLP, Asset Management Arm
133,229US$498.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 16:30
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

aTyr Pharma, Inc. is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James BirchenoughBMO Capital Markets Equity Research
Joseph PantginisH.C. Wainwright & Co.
Roger SongJefferies LLC